The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SWOG S9005: Double blind phase III randomized trial of the anti-progestin agent mifepristone in the treatment of unresectable meningioma.
 
Yongli Ji
Employment - Shire (I)
Stock and Other Ownership Interests - Shire (I)
 
Cathryn J Rankin
Employment - Pathology Associate and Medical Laboratory (I)
 
Steven M. Grunberg
No Relationships to Disclose
 
Andy Sherrod
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Becton Dickinson; Invacare; Johnson & Johnson; Lilly; Pfizer
 
Jamshid Ahmadi
No Relationships to Disclose
 
Lynn G. Feun
No Relationships to Disclose
 
Ruth Fredericks
No Relationships to Disclose
 
Christy Ann Russell
No Relationships to Disclose
 
Fairooz F. Kabbinavar
No Relationships to Disclose
 
Keith Stelzer
No Relationships to Disclose
 
Anne F. Schott
Research Funding - Dompé Farmaceutici
Patents, Royalties, Other Intellectual Property - Systems and Methods for Tissue Imaging, 8,185,186, Inventor, Submitted on 04/2008. This is a patent for use of diffusion MRI technology to quantitate response to neoadjuvant breast cancer therapy.
 
Claire F. Verschraegen
No Relationships to Disclose